Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
Abstract Background Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunotherapeutic capable of activating innate immune defenses for non-specific protection or early t...
Main Authors: | William Wheat, Lyndah Chow, Alana Kuzmik, Sirikul Soontararak, Jade Kurihara, Michael Lappin, Steven Dow |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-019-2073-8 |
Similar Items
-
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
by: Allison M. Owen, et al.
Published: (2021-02-01) -
Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
by: Sirikul Soontararak, et al.
Published: (2019-01-01) -
Monocyte Reconstitution and Gut Microbiota Composition after Hematopoietic Stem Cell Transplantation
by: Sejal Morjaria, et al.
Published: (2020-11-01) -
Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
by: Darlington, Donna
Published: (2014) -
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
by: Kuan-Yin Shen, et al.
Published: (2020-03-01)